KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$92.0 million.

  • Novartis Ag's Other Non Operating Income fell 37878.79% to -$92.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$136.0 million, marking a year-over-year decrease of 19714.29%. This contributed to the annual value of -$136.0 million for FY2025, which is 19714.29% down from last year.
  • Latest data reveals that Novartis Ag reported Other Non Operating Income of -$92.0 million as of Q4 2025, which was down 37878.79% from -$20.0 million recorded in Q3 2025.
  • Novartis Ag's Other Non Operating Income's 5-year high stood at $104.0 million during Q1 2023, with a 5-year trough of -$92.0 million in Q4 2025.
  • Moreover, its 5-year median value for Other Non Operating Income was $15.5 million (2022), whereas its average is $8.9 million.
  • Per our database at Business Quant, Novartis Ag's Other Non Operating Income surged by 43125.0% in 2023 and then crashed by 37878.79% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Other Non Operating Income stood at -$26.0 million in 2021, then surged by 192.31% to $24.0 million in 2022, then dropped by 25.0% to $18.0 million in 2023, then skyrocketed by 83.33% to $33.0 million in 2024, then plummeted by 378.79% to -$92.0 million in 2025.
  • Its Other Non Operating Income stands at -$92.0 million for Q4 2025, versus -$20.0 million for Q3 2025 and -$41.0 million for Q2 2025.